Schroder Investment Management Group bought a new stake in shares of Addus Homecare Co. (NASDAQ:ADUS) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 51,048 shares of the company’s stock, valued at approximately $3,581,000. Schroder Investment Management Group owned approximately 0.39% of Addus Homecare as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in ADUS. American International Group Inc. grew its stake in shares of Addus Homecare by 26.3% in the third quarter. American International Group Inc. now owns 6,277 shares of the company’s stock worth $440,000 after acquiring an additional 1,309 shares during the last quarter. BlackRock Inc. grew its stake in shares of Addus Homecare by 24.9% in the third quarter. BlackRock Inc. now owns 731,017 shares of the company’s stock worth $51,281,000 after acquiring an additional 145,736 shares during the last quarter. Martingale Asset Management L P grew its stake in shares of Addus Homecare by 3.9% in the third quarter. Martingale Asset Management L P now owns 32,103 shares of the company’s stock worth $2,253,000 after acquiring an additional 1,200 shares during the last quarter. Thomson Horstmann & Bryant Inc. grew its stake in shares of Addus Homecare by 27.5% in the third quarter. Thomson Horstmann & Bryant Inc. now owns 190,040 shares of the company’s stock worth $13,331,000 after acquiring an additional 40,956 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of Addus Homecare by 137.0% in the third quarter. Alliancebernstein L.P. now owns 107,088 shares of the company’s stock worth $7,512,000 after acquiring an additional 61,898 shares during the last quarter. Institutional investors own 92.89% of the company’s stock.
In related news, EVP Laurie Manning sold 1,000 shares of the stock in a transaction on Monday, November 19th. The stock was sold at an average price of $71.91, for a total transaction of $71,910.00. Following the sale, the executive vice president now directly owns 11,537 shares of the company’s stock, valued at $829,625.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Eos Capital Partners Iii L. P sold 540,000 shares of the stock in a transaction dated Wednesday, November 28th. The shares were sold at an average price of $72.46, for a total value of $39,128,400.00. The disclosure for this sale can be found here. Insiders have sold 923,400 shares of company stock worth $66,935,850 over the last ninety days. 34.80% of the stock is currently owned by insiders.
Addus Homecare stock opened at $74.40 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 4.19 and a current ratio of 4.19. Addus Homecare Co. has a one year low of $31.67 and a one year high of $77.82. The firm has a market cap of $997.18 million, a P/E ratio of 46.99, a price-to-earnings-growth ratio of 3.01 and a beta of -0.27.
Addus Homecare (NASDAQ:ADUS) last released its quarterly earnings data on Tuesday, November 6th. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.40 by $0.08. Addus Homecare had a return on equity of 9.55% and a net margin of 3.25%. The company had revenue of $137.63 million for the quarter, compared to analysts’ expectations of $139.43 million. As a group, equities analysts anticipate that Addus Homecare Co. will post 1.69 EPS for the current fiscal year.
ADUS has been the topic of a number of recent research reports. ValuEngine raised Addus Homecare from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 4th. BidaskClub cut Addus Homecare from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 10th. Jefferies Financial Group initiated coverage on Addus Homecare in a research note on Tuesday, August 21st. They issued a “buy” rating and a $75.00 target price on the stock. Oppenheimer increased their target price on Addus Homecare from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 7th. Finally, Zacks Investment Research cut Addus Homecare from a “hold” rating to a “strong sell” rating in a research note on Monday, August 13th. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $73.50.
ILLEGAL ACTIVITY NOTICE: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/12/08/schroder-investment-management-group-invests-3-58-million-in-addus-homecare-co-adus.html.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Recommended Story: NASDAQ
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.